Lundbecks hovedpine, sving i AMBUlancen og høje oliepriser
-
Lyt og se med, når Per Hansen og Helge Larsen i afsnit 68 af Investeringspodcasten taler om Ambus yoyo-aktivitet i C25-indekset, hvorvidt Lundbeck har fået kurs-migræne, hvad oliepriser over 70 USD betyder og ikke mindst det kommende sommerferiemarked.
-
Har Lundbeck fået godkendt deres migrænemiddel Vyepti på det europæiske marked? Lundbeck sendte en ansøgning til EMA i december 2020 : https://medwatch.dk/Medicinal___Biotek/article12649550.ece
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind